BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
bharat parenterals limited stock

Bharat Parenterals Limited Share Price

1739.9 -11.29 (-0.64%)
Dec 11 2024 03:28 PM Pharmaceuticals NSE: BPLPHARMA

Bharat Parenterals Limited Share Price Update

As of the latest trading session, Bharat Parenterals Limited share price is currently at 1739.9, which is down by -11.29 from its previous closing. Today, the stock has fluctuated between 1718.00 and 1750.00. Over the past year, Bharat Parenterals Limited has achieved a return of 190.00 %. In the last month alone, the return has been 20.44 %. Read More...

Bharat Parenterals Limited Performance

Day Range

Low1718.00 High1750.00
1733.95

52 Week Range

Low 582.00 High 1870.00
1733.95

Bharat Parenterals Limited Share Price

541096

BPLPHARMA

img img img img
No Data Available

Open Price

1749.00

Prev. Close

1751.20

Volume (Shares)

226.00

Total traded value

3.89

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

Bharat Parenterals Limited Fundamentals


(Standalone)

Market Cap (Cr) 1012.56
PE Ratio (TTM) 46.30
Book Value / Share 548.29
Beta 0.82
ROE 11.16%
EPS (TTM) 37.45
Dividend Yield 0.05%
Net Profit Qtr (Cr) 5.49

Bharat Parenterals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 64.45
Operating Expense 61.42
Net Profit 5.49
Net Profit Margin (%) 8.51
Earnings Per Share (EPS) 7.90
EBITDA 10.26
Effective Tax Rate (%) 28.04
Particulars JUN 2024 (Values in Cr)
Revenue 92.06
Operating Expense 79.70
Net Profit 12.18
Net Profit Margin (%) 13.23
Earnings Per Share (EPS) 20.26
EBITDA 18.89
Effective Tax Rate (%) 25.09
Particulars MAR 2024 (Values in Cr)
Revenue 65.64
Operating Expense 64.60
Net Profit 3.07
Net Profit Margin (%) 4.67
Earnings Per Share (EPS) 5.15
EBITDA 6.98
Effective Tax Rate (%) 28.27
Particulars DEC 2023 (Values in Cr)
Revenue 58.80
Operating Expense 54.30
Net Profit 5.07
Net Profit Margin (%) 8.62
Earnings Per Share (EPS) 8.65
EBITDA 9.18
Effective Tax Rate (%) 26.52
Particulars SEP 2023 (Values in Cr)
Revenue 59.81
Operating Expense 55.60
Net Profit 5.56
Net Profit Margin (%) 9.29
Earnings Per Share (EPS) 9.62
EBITDA 9.88
Effective Tax Rate (%) 27.50
Particulars MAR 2024 (Values in Cr)
Revenue 254.16
Operating Expense 235.32
Net Profit 22.59
Net Profit Margin (%) 8.88
Earnings Per Share (EPS) 38.81
EBITDA 40.39
Effective Tax Rate (%) 26.65
Particulars MAR 2023 (Values in Cr)
Revenue 217.98
Operating Expense 204.65
Net Profit 24.34
Net Profit Margin (%) 11.16
Earnings Per Share (EPS) 42.40
EBITDA 40.21
Effective Tax Rate (%) 24.33
Particulars MAR 2022 (Values in Cr)
Revenue 212.01
Operating Expense 191.42
Net Profit 21.30
Net Profit Margin (%) 10.04
Earnings Per Share (EPS) 37.11
EBITDA 36.00
Effective Tax Rate (%) 24.92
Particulars MAR 2021 (Values in Cr)
Revenue 203.67
Operating Expense 185.32
Net Profit 20.21
Net Profit Margin (%) 9.92
Earnings Per Share (EPS) 35.27
EBITDA 33.44
Effective Tax Rate (%) 25.20
Particulars MAR 2020 (Values in Cr)
Revenue 226.33
Operating Expense 202.86
Net Profit 26.30
Net Profit Margin (%) 11.62
Earnings Per Share (EPS) 45.90
EBITDA 41.69
Effective Tax Rate (%) 24.74
Particulars MAR 2024 (Values in Cr)
Book Value / Share 338.96
ROE % 5.53
ROCE % 7.71
Total Debt to Total Equity 0.55
EBITDA Margin 12.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 316.55
ROE % 9.01
ROCE % 12.50
Total Debt to Total Equity 0.19
EBITDA Margin 14.69
Particulars MAR 2022 (Values in Cr)
Book Value / Share 287.16
ROE % 13.44
ROCE % 17.10
Total Debt to Total Equity 0.10
EBITDA Margin 16.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 251.09
ROE % 15.51
ROCE % 20.16
Total Debt to Total Equity 0.05
EBITDA Margin 16.58
Particulars MAR 2020 (Values in Cr)
Book Value / Share 206.27
ROE % 22.75
ROCE % 30.74
Total Debt to Total Equity 0.03
EBITDA Margin 17.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 367.05
ROE % 11.16
ROCE % 12.94
Total Debt to Total Equity 0.32
EBITDA Margin 14.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 330.86
ROE % 11.08
ROCE % 13.60
Total Debt to Total Equity 0.17
EBITDA Margin 13.62
Particulars MAR 2022 (Values in Cr)
Book Value / Share 287.72
ROE % 13.74
ROCE % 17.51
Total Debt to Total Equity 0.09
EBITDA Margin 15.08
Particulars MAR 2021 (Values in Cr)
Book Value / Share 251.22
ROE % 15.13
ROCE % 19.72
Total Debt to Total Equity 0.05
EBITDA Margin 16.60
Particulars MAR 2020 (Values in Cr)
Book Value / Share 214.92
ROE % 23.92
ROCE % 31.60
Total Debt to Total Equity 0.03
EBITDA Margin 18.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 12.09
Total Assets 503.82
Total Liabilities 503.82
Total Equity 238.17
Share Outstanding 5819666
Price to Book Ratio 3.06
Return on Assets (%) 2.88
Return on Capital (%) 3.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.98
Total Assets 350.34
Total Liabilities 350.34
Total Equity 217.89
Share Outstanding 5774666
Price to Book Ratio 1.02
Return on Assets (%) 4.69
Return on Capital (%) 6.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.67
Total Assets 226.05
Total Liabilities 226.05
Total Equity 170.14
Share Outstanding 5774666
Price to Book Ratio 1.19
Return on Assets (%) 9.31
Return on Capital (%) 11.21
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 198.64
Total Liabilities 198.64
Total Equity 143.81
Share Outstanding 5729666
Price to Book Ratio 1.33
Return on Assets (%) 10.26
Return on Capital (%) 13.07
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 10.40
Total Assets 187.49
Total Liabilities 187.49
Total Equity 118.18
Share Outstanding 5729666
Price to Book Ratio 0.66
Return on Assets (%) 12.87
Return on Capital (%) 20.31
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.66
Total Assets 387.15
Total Liabilities 387.15
Total Equity 213.60
Share Outstanding 5819666
Price to Book Ratio 3.06
Return on Assets (%) 5.83
Return on Capital (%) 7.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.42
Total Assets 308.02
Total Liabilities 308.02
Total Equity 191.06
Share Outstanding 5774666
Price to Book Ratio 1.02
Return on Assets (%) 7.90
Return on Capital (%) 10.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.60
Total Assets 218.00
Total Liabilities 218.00
Total Equity 166.15
Share Outstanding 5774666
Price to Book Ratio 1.19
Return on Assets (%) 9.77
Return on Capital (%) 11.76
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.15
Total Assets 196.23
Total Liabilities 196.23
Total Equity 143.94
Share Outstanding 5729666
Price to Book Ratio 1.33
Return on Assets (%) 10.29
Return on Capital (%) 12.94
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.98
Total Assets 192.29
Total Liabilities 192.29
Total Equity 123.14
Share Outstanding 5729666
Price to Book Ratio 0.66
Return on Assets (%) 13.67
Return on Capital (%) 21.23
Particulars MAR 2024 (Values in Cr)
Net Income 18.72
Cash from Operations 4.75
Cash from Investing -104.78
Cash from Financing 110.42
Net change in Cash 0.93
Free Cash Flow 109.05
Particulars MAR 2023 (Values in Cr)
Net Income 23.54
Cash from Operations 30.45
Cash from Investing -77.81
Cash from Financing 60.59
Net change in Cash 4.44
Free Cash Flow 122.05
Particulars MAR 2022 (Values in Cr)
Net Income 27.87
Cash from Operations 4.60
Cash from Investing -6.63
Cash from Financing 9.42
Net change in Cash 1.72
Free Cash Flow 43.55
Particulars MAR 2021 (Values in Cr)
Net Income 27.12
Cash from Operations 31.12
Cash from Investing -43.37
Cash from Financing 10.49
Net change in Cash -8.42
Free Cash Flow 31.96
Particulars MAR 2020 (Values in Cr)
Net Income 32.79
Cash from Operations 24.49
Cash from Investing -12.60
Cash from Financing -2.81
Net change in Cash -0.96
Free Cash Flow 39.50
Particulars MAR 2024 (Values in Cr)
Net Income 30.80
Cash from Operations -13.41
Cash from Investing -16.09
Cash from Financing 34.17
Net change in Cash -4.84
Free Cash Flow -3.05
Particulars MAR 2023 (Values in Cr)
Net Income 32.16
Cash from Operations -2.77
Cash from Investing -13.94
Cash from Financing 28.52
Net change in Cash 3.01
Free Cash Flow 2.28
Particulars MAR 2022 (Values in Cr)
Net Income 28.36
Cash from Operations -16.40
Cash from Investing 21.75
Cash from Financing 2.24
Net change in Cash 1.92
Free Cash Flow -11.64
Particulars MAR 2021 (Values in Cr)
Net Income 27.01
Cash from Operations 28.55
Cash from Investing -40.70
Cash from Financing 10.54
Net change in Cash -8.28
Free Cash Flow 28.55
Particulars MAR 2020 (Values in Cr)
Net Income 34.95
Cash from Operations 24.52
Cash from Investing -12.60
Cash from Financing -3.06
Net change in Cash -1.18
Free Cash Flow 39.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1743.00
  • 26 Days 1634.40
  • 10 Days 1724.10
  • 50 Days 1587.00
  • 12 Days 1718.70
  • 100 Days 1568.20
  • 20 Days 1661.90
  • 200 Days 1187.60
1757.10
PIVOT
First Resistance 1784.10
Second Resistance 1817.00
Third Resistance 1844.00
First Support 1724.20
Second Support 1697.20
Third Support 1664.30
RSI 64.52
MACD 84.27
Commodity Channel Index (CCI) 70.79
ADX 45.10
Williams % R -27.56

Over 1 Month

down

20.44

Over 3 Months

down

12.11

Over 6 Months

down

25.25

Over 1 Year

down

190.00

Over 3 Years

down

67.76

Over 5 Years

down

59.06

Bharat Parenterals Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Bharat Parenterals Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
32.17
Promoter Holdings
67.19
FII
0.07
DII
0.54
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Desai Shares And Stock Private Limited Shareholding of Promoter and Promoter Group 2731536.0 39.63
Himaben Bharatbhai Desai Shareholding of Promoter and Promoter Group 962499.0 13.97
Bharat Rameshbhai Desai Shareholding of Promoter and Promoter Group 741655.0 10.76
Asoj Soft Caps Pvtltd(anchor) Public Shareholding 340130.0 4.94
Ashish Kacholia Public Shareholding 129018.0 1.87
Madhulika Agarwal Public Shareholding 129018.0 1.87
Sohini Girish Patel Public Shareholding 97500.0 1.41
Manohar Devabhaktuni Public Shareholding 94265.0 1.37
Rajasthan Global Securities Pvt Ltd Public Shareholding 93744.0 1.36
Bhahim Bhartkumar Desai Shareholding of Promoter and Promoter Group 90281.0 1.31
Neo Apex Share Broking Services Llp Public Shareholding 88469.0 1.28
Nikita Bhahim Desai Shareholding of Promoter and Promoter Group 84267.0 1.22
Varenyam Healthcare Pvt Ltd Shareholding of Promoter and Promoter Group 16261.0 0.24
Shailesh Govindlal Desai Shareholding of Promoter and Promoter Group 2600.0 0.04
Lataben Shaileshkumar Parikh Shareholding of Promoter and Promoter Group 1699.0 0.02
Pooja P Shah Shareholding of Promoter and Promoter Group 500.0 0.01

Bharat Parenterals Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-25 0.75 Final 2023-09-25 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Bharat Parenterals Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Bharat Parenterals Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Bharat Parenterals Ltd?

Answer Field

The share price of Bharat Parenterals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 1733.95.

What is the Market Cap of Bharat Parenterals Ltd?

Answer Field

The market cap of Bharat Parenterals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 11,95.00 Cr. as of now.

What is the 52 Week High and Low of Bharat Parenterals Ltd?

Answer Field

The 52 Week High and Low of Bharat Parenterals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1870.00 and ₹ 582.00.

How to Buy Bharat Parenterals Ltd share?

Answer Field

You can trade in Bharat Parenterals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Bharat Parenterals Ltd?

Answer Field

The 1 year returns on the stock has been 190.00%.

What is the Current Share Price of Bharat Parenterals Ltd?

Answer Field

Bharat Parenterals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1733.95 as on Dec 11 2024 03:28 PM.

What is the Market Cap of Bharat Parenterals Ltd Share?

Answer Field

The market cap of Bharat Parenterals Ltd for NSE ₹ 0.0 & for BSE ₹ 11,95.00 as on Dec 11 2024 03:28 PM.

What is the P/E Ratio of Bharat Parenterals Ltd Share?

Answer Field

As on Dec 11 2024 03:28 PM the price-to-earnings (PE) ratio for Bharat Parenterals Ltd share is 46.30.

What is the PB ratio of Bharat Parenterals Ltd Share?

Answer Field

As on Dec 11 2024 03:28 PM, the price-to-book (PB) ratio for Bharat Parenterals Ltd share is 548.29.

How to Buy Bharat Parenterals Ltd Share?

Answer Field

You can trade in Bharat Parenterals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bharat Parenterals Ltd Share on Bajaj Broking App?

Answer Field

To buy Bharat Parenterals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bharat Parenterals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader